A carregar...
Reversing cognitive-decline in older adults in an open-label clinical trial: novel mechanisms and the role of GlyNAC
Age-associated cognitive-decline is an important risk factor for Alzheimer’s disease, but interventions are lacking. We conducted an open-label trial to test our hypotheses on whether: (1) compared to 8 healthy young adults (25y), 8 ‘healthy’ older adults (74y) have cognitive decline, decreased gluc...
Na minha lista:
| Publicado no: | Innov Aging |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7742443/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igaa057.3157 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|